SZOT MATTHEW K (Chief Financial Officer) sold 20.5% of their position (3.49K shares) of CADRENAL THERAPEUTICS, INC. on the open market
Open‑market sale worth $49.0K — a significant reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 10/14/2025ACC: 0001213900-25-098718
Officer· Chief Financial Officer
Since Jan 2023
-3.49K
Net shares
Net seller
$49.0K
Total sold
2
Open market trades
0B · 2S
2
Total transactions
3.49K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
−1.69K
Price / share
$13.99
Trade value
$23.69K
% of position
9.9%
10/9/2025
17.03K→15.33K
Common Stock
Direct
Shares
−1.80K
Price / share
$14.07
Trade value
$25.33K
% of position
11.7%
10/13/2025
15.33K→13.53K
Total
Net shares
−3.49K
Net value
-$49.01K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 10/9/2025 | S · Sale | −1.69K | $13.99 | $23.69K | 9.9% | 17.03K | 15.33K |
| Common Stock Direct | 10/13/2025 | S · Sale | −1.80K | $14.07 | $25.33K | 11.7% | 15.33K | 13.53K |
| Total | −3.49K | -$49.01K | ||||||
Derivative Transactions0
No derivative transactions reported